{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T22:12:19Z","timestamp":1774563139063,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12957-017-1150-3","type":"journal-article","created":{"date-parts":[[2017,4,12]],"date-time":"2017-04-12T22:33:19Z","timestamp":1492036399000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Lower limb function and quality of life after ILP for soft-tissue sarcoma"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1011-7822","authenticated-orcid":false,"given":"Lars Erik","family":"Podleska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nevda","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhad","family":"Farzaliyev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"P\u00f6ttgen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Taeger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,13]]},"reference":[{"key":"1150_CR1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0959-8049(02)00729-3","volume":"39","author":"A Bottomley","year":"2003","unstructured":"Bottomley A, Vanvoorden V, Flechtner H, Therasse P. The challenges and achievements involved in implementing quality of life research in cancer clinical trials. Eur J Cancer. 2003;39:275\u201385.","journal-title":"Eur J Cancer"},{"key":"1150_CR2","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/jso.23591","volume":"109","author":"J Jakob","year":"2014","unstructured":"Jakob J, Tunn PU, Hayes AJ, Pilz LR, Nowak K, Hohenberger P. Oncological outcome of primary non-metastatic soft tissue sarcoma treated by neoadjuvant isolated limb perfusion and tumor resection. J Surg Oncol. 2014;109:786\u201390.","journal-title":"J Surg Oncol"},{"key":"1150_CR3","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1245\/s10434-011-2196-z","volume":"19","author":"R Olofsson","year":"2012","unstructured":"Olofsson R, Bergh P, Berlin O, Engstrom K, Gunterberg B, Hansson M, et al. Long-term outcome of isolated limb perfusion in advanced soft tissue sarcoma of the extremity. Ann Surg Oncol. 2012;19:1800\u20137.","journal-title":"Ann Surg Oncol"},{"key":"1150_CR4","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/jso.22121","volume":"105","author":"JP Deroose","year":"2012","unstructured":"Deroose JP, van Geel AN, Burger JW, Eggermont AM, Verhoef C. Isolated limb perfusion with TNF-alpha and melphalan for distal parts of the limb in soft tissue sarcoma patients. J Surg Oncol. 2012;105:563\u20139.","journal-title":"J Surg Oncol"},{"key":"1150_CR5","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/cncr.21802","volume":"106","author":"DJ Grunhagen","year":"2006","unstructured":"Grunhagen DJ, de Wilt JH, Graveland WJ, Verhoef C, van Geel AN, Eggermont AM. Outcome and prognostic factor analysis of 217 consecutive isolated limb perfusions with tumor necrosis factor-alpha and melphalan for limb-threatening soft tissue sarcoma. Cancer. 2006;106:1776\u201384.","journal-title":"Cancer"},{"key":"1150_CR6","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/annonc\/mdi229","volume":"16","author":"S Bonvalot","year":"2005","unstructured":"Bonvalot S, Laplanche A, Lejeune F, Stoeckle E, Le Pechoux C, Vanel D, et al. Limb salvage with isolated perfusion for soft tissue sarcoma: could less TNF-alpha be better? Ann Oncol. 2005;16:1061\u20138.","journal-title":"Ann Oncol"},{"key":"1150_CR7","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1200\/JCO.1996.14.10.2653","volume":"14","author":"AM Eggermont","year":"1996","unstructured":"Eggermont AM, Schraffordt Koops H, Lienard D, Kroon BB, van Geel AN, Hoekstra HJ, et al. Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial. J Clin Oncol. 1996;14:2653\u201365.","journal-title":"J Clin Oncol"},{"key":"1150_CR8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/02656736.2015.1109146","volume":"32","author":"D Andreou","year":"2016","unstructured":"Andreou D, Werner M, Pink D, Traub F, Schuler MK, Gosheger G, et al. Histological response assessment following neoadjuvant isolated limb perfusion in patients with primary, localised, high-grade soft tissue sarcoma. Int J Hyperthermia. 2016;32:159\u201364.","journal-title":"Int J Hyperthermia"},{"key":"1150_CR9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejso.2012.10.009","volume":"39","author":"F Grabellus","year":"2012","unstructured":"Grabellus F, Podleska LE, Sheu SY, Bauer S, Pottgen C, Kloeters C, et al. Neoadjuvant treatment improves capsular integrity and the width of the fibrous capsule of high-grade soft-tissue sarcomas. Eur J Surg Oncol. 2012;39:61\u20137.","journal-title":"Eur J Surg Oncol"},{"key":"1150_CR10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/jso.21724","volume":"103","author":"F Grabellus","year":"2011","unstructured":"Grabellus F, Kraft C, Sheu-Grabellus SY, Bauer S, Podleska LE, Lauenstein TC, et al. Tumor vascularization and histopathologic regression of soft tissue sarcomas treated with isolated limb perfusion with TNF-alpha and melphalan. J Surg Oncol. 2011;103:371\u20139.","journal-title":"J Surg Oncol"},{"key":"1150_CR11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1245\/s10434-010-1400-x","volume":"18","author":"JP Deroose","year":"2011","unstructured":"Deroose JP, Burger JW, van Geel AN, den Bakker MA, de Jong JS, Eggermont AM, et al. Radiotherapy for soft tissue sarcomas after isolated limb perfusion and surgical resection: essential for local control in all patients? Ann Surg Oncol. 2011;18:321\u20137.","journal-title":"Ann Surg Oncol"},{"key":"1150_CR12","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/00000658-199612000-00011","volume":"224","author":"AM Eggermont","year":"1996","unstructured":"Eggermont AM, Schraffordt Koops H, Klausner JM, Kroon BB, Schlag PM, Lienard D, et al. Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience. Ann Surg. 1996;224:756\u201365.","journal-title":"Ann Surg"},{"key":"1150_CR13","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/740279","author":"P Reichardt","year":"2012","unstructured":"Reichardt P, Leahy M, Garcia Del Muro X, Ferrari S, Martin J, Gelderblom H, et al. Quality of life and utility in patients with metastatic soft tissue and bone sarcoma: the Sarcoma Treatment and Burden of Illness in North America and Europe (SABINE) Study. Sarcoma. 2012. doi: 10.1155\/2012\/740279 .","journal-title":"Sarcoma"},{"key":"1150_CR14","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1245\/s10434-010-0915-5","volume":"17","author":"KM Davidge","year":"2010","unstructured":"Davidge KM, Wunder J, Tomlinson G, Wong R, Lipa J, Davis AM. Function and health status outcomes following soft tissue reconstruction for limb preservation in extremity soft tissue sarcoma. Ann Surg Oncol. 2010;17:1052\u201362.","journal-title":"Ann Surg Oncol"},{"key":"1150_CR15","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.2106\/00004623-199072100-00008","volume":"72","author":"IE Harris","year":"1990","unstructured":"Harris IE, Leff AR, Gitelis S, Simon MA. Function after amputation, arthrodesis, or arthroplasty for tumors about the knee. J Bone Joint Surg Am. 1990;72:1477\u201385.","journal-title":"J Bone Joint Surg Am"},{"key":"1150_CR16","doi-asserted-by":"crossref","first-page":"462","DOI":"10.2106\/00004623-199904000-00003","volume":"81","author":"A Hillmann","year":"1999","unstructured":"Hillmann A, Hoffmann C, Gosheger G, Krakau H, Winkelmann W. Malignant tumor of the distal part of the femur or the proximal part of the tibia: endoprosthetic replacement or rotationplasty. Functional outcome and quality-of-life measurements. J Bone Joint Surg Am. 1999;81:462\u20138.","journal-title":"J Bone Joint Surg Am"},{"key":"1150_CR17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.radonc.2004.12.020","volume":"75","author":"AM Davis","year":"2005","unstructured":"Davis AM, O\u2019Sullivan B, Turcotte R, Bell R, Catton C, Chabot P, et al. Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiother Oncol. 2005;75:48\u201353.","journal-title":"Radiother Oncol"},{"key":"1150_CR18","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/171342","author":"MH Tang","year":"2012","unstructured":"Tang MH, Pan DJ, Castle DJ, Choong PF. A systematic review of the recent quality of life studies in adult extremity sarcoma survivors. Sarcoma. 2012. doi: 10.1155\/2012\/171342 .","journal-title":"Sarcoma"},{"key":"1150_CR19","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1200\/JCO.2002.03.084","volume":"20","author":"AM Davis","year":"2002","unstructured":"Davis AM, O\u2019Sullivan B, Bell RS, Turcotte R, Catton CN, Wunder JS, et al. Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma. J Clin Oncol. 2002;20:4472\u20137.","journal-title":"J Clin Oncol"},{"key":"1150_CR20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/13577140120099173","volume":"5","author":"C Eiser","year":"2001","unstructured":"Eiser C, Darlington AS, Stride CB, Grimer R. Quality of life implications as a consequence of surgery: limb salvage, primary and secondary amputation. Sarcoma. 2001;5:189\u201395.","journal-title":"Sarcoma"},{"key":"1150_CR21","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1245\/ASO.2006.05.023","volume":"13","author":"KM Thijssens","year":"2006","unstructured":"Thijssens KM, Hoekstra-Weebers JE, van Ginkel RJ, Hoekstra HJ. Quality of life after hyperthermic isolated limb perfusion for locally advanced extremity soft tissue sarcoma. Ann Surg Oncol. 2006;13:864\u201371.","journal-title":"Ann Surg Oncol"},{"key":"1150_CR22","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1302\/0301-620X.90B6.19805","volume":"90","author":"LH Aksnes","year":"2008","unstructured":"Aksnes LH, Bauer HC, Jebsen NL, Folleras G, Allert C, Haugen GS, et al. Limb-sparing surgery preserves more function than amputation: a Scandinavian sarcoma group study of 118 patients. J Bone Joint Surg (Br). 2008;90:786\u201394.","journal-title":"J Bone Joint Surg (Br)"},{"key":"1150_CR23","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/sj.bjc.6602104","volume":"91","author":"A Zahlten-Hinguranage","year":"2004","unstructured":"Zahlten-Hinguranage A, Bernd L, Ewerbeck V, Sabo D. Equal quality of life after limb-sparing or ablative surgery for lower extremity sarcomas. Br J Cancer. 2004;91:1012\u20134.","journal-title":"Br J Cancer"},{"key":"1150_CR24","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0277-5379(82)90235-8","volume":"18","author":"J Wieberdink","year":"1982","unstructured":"Wieberdink J, Benckhuysen C, Braat RP, van Slooten EA, Olthuis GA. Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions. Eur J Cancer Clin Oncol. 1982;18:905\u201310.","journal-title":"Eur J Cancer Clin Oncol"},{"key":"1150_CR25","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1053\/ejso.2001.1124","volume":"27","author":"BC Vrouenraets","year":"2001","unstructured":"Vrouenraets BC, Eggermont AM, Hart AA, Klaase JM, van Geel AN, Nieweg OE, et al. Regional toxicity after isolated limb perfusion with melphalan and tumour necrosis factor-alpha versus toxicity after melphalan alone. Eur J Surg Oncol. 2001;27:390\u20135.","journal-title":"Eur J Surg Oncol"},{"key":"1150_CR26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1477-7819-11-185","volume":"11","author":"B Schwindenhammer","year":"2013","unstructured":"Schwindenhammer B, Podleska LE, Kutritz A, Bauer S, Sheu SY, Taeger G, et al. The pathologic response of resected synovial sarcomas to hyperthermic isolated limb perfusion with melphalan and TNF-alpha: a comparison with the whole group of resected soft tissue sarcomas. World J Surg Oncol. 2013;11:185.","journal-title":"World J Surg Oncol"},{"key":"1150_CR27","volume-title":"The EORTC QLQ-C30 scoring manual","author":"PM Fayers","year":"2001","unstructured":"Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A. The EORTC QLQ-C30 scoring manual. 3rd ed. Brussels: The European Organisation for Research and Treatment of Cancer; 2001.","edition":"3"},{"key":"1150_CR28","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organisation for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365\u201376.","journal-title":"J Natl Cancer Inst"},{"key":"1150_CR29","first-page":"1","volume":"259","author":"P Gustafson","year":"1994","unstructured":"Gustafson P. Soft tissue sarcoma: epidemiology and prognosis in 508 patients. Acta Orthop Scand Suppl. 1994;259:1\u201331.","journal-title":"Acta Orthop Scand Suppl"},{"key":"1150_CR30","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/000164701317323417","volume":"72","author":"CS Trovik","year":"2001","unstructured":"Trovik CS, Bauer HC, Berlin O, Tukiainen E, Erlanson M, Gustafson P, et al. Local recurrence of deep-seated, high-grade, soft tissue sarcoma: 459 patients from the Scandinavian Sarcoma Group Register. Acta Orthop Scand. 2001;72:160\u20136.","journal-title":"Acta Orthop Scand"},{"key":"1150_CR31","volume-title":"EORTC QLQ-C30 reference values for the general population and all cancer patients","author":"NW Scott","year":"2008","unstructured":"Scott NW, Fayers PM, Aaronson NK, Bottomley A, de Graeff A, Groenvold M, et al. EORTC QLQ-C30 reference values for the general population and all cancer patients. 1st ed. Brussels: The European Organisation for Research and Treatment of Cancer; 2008.","edition":"1"},{"key":"1150_CR32","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.2106\/00004623-199909000-00006","volume":"81","author":"MF Swiontkowski","year":"1999","unstructured":"Swiontkowski MF, Engelberg R, Martin DP, Agel J. Short musculoskeletal function assessment questionnaire: validity, reliability, and responsiveness. J Bone Joint Surg Am. 1999;81:1245\u201360.","journal-title":"J Bone Joint Surg Am"},{"key":"1150_CR33","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/jor.1100140204","volume":"14","author":"R Engelberg","year":"1996","unstructured":"Engelberg R, Martin DP, Agel J, Obremsky W, Coronado G, Swiontkowski MF. Musculoskeletal Function Assessment instrument: criterion and construct validity. J Orthop Res. 1996;14:182\u201392.","journal-title":"J Orthop Res"},{"key":"1150_CR34","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1055\/s-2000-10151","volume":"138","author":"A Konig","year":"2000","unstructured":"Konig A, Kirschner S, Walther M, Bohm D, Faller H. I. Cultural adaptation, practicability and reliability evaluation of the Musculoskeletal Functional Assessment Questionnaire. Z Orthop Ihre Grenzgeb. 2000;138:295\u2013301.","journal-title":"Z Orthop Ihre Grenzgeb"},{"key":"1150_CR35","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1055\/s-2000-10152","volume":"138","author":"A Konig","year":"2000","unstructured":"Konig A, Walther M, Matzer M, Heesen T, Kirschner S, Faller H. II. Validity and sensitivity to change of the Musculoskeletal Functional Assessment Questionnaire in primary gonarthrosis and total endoprosthetic joint replacement. Z Orthop Ihre Grenzgeb. 2000;138:302\u20135.","journal-title":"Z Orthop Ihre Grenzgeb"},{"key":"1150_CR36","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.2106\/00004623-199709000-00006","volume":"79","author":"DP Martin","year":"1997","unstructured":"Martin DP, Engelberg R, Agel J, Swiontkowski MF. Comparison of the Musculoskeletal Function Assessment questionnaire with the Short Form-36, the Western Ontario and McMaster Universities Osteoarthritis Index, and the Sickness Impact Profile health-status measures. J Bone Joint Surg Am. 1997;79:1323\u201335.","journal-title":"J Bone Joint Surg Am"},{"key":"1150_CR37","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.apmr.2006.12.032","volume":"88","author":"CE Schwartz","year":"2007","unstructured":"Schwartz CE, Andresen EM, Nosek MA, Krahn GL. Response shift theory: important implications for measuring quality of life in people with disability. Arch Phys Med Rehabil. 2007;88:529\u201336.","journal-title":"Arch Phys Med Rehabil"},{"key":"1150_CR38","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/S0277-9536(99)00045-3","volume":"48","author":"MA Sprangers","year":"1999","unstructured":"Sprangers MA, Schwartz CE. Integrating response shift into health-related quality of life research: a theoretical model. Soc Sci Med. 1999;48:1507\u201315.","journal-title":"Soc Sci Med"},{"key":"1150_CR39","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/pon.3538","volume":"23","author":"P Blanckenburg von","year":"2014","unstructured":"von Blanckenburg P, Seifart U, Conrad N, Exner C, Rief W, Nestoriuc Y. Quality of life in cancer rehabilitation: the role of life goal adjustment. Psychooncology. 2014;23:1149\u201356.","journal-title":"Psychooncology"},{"key":"1150_CR40","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/(SICI)1099-1611(199606)5:2<103::AID-PON221>3.0.CO;2-W","volume":"5","author":"F Porzsolt","year":"1996","unstructured":"Porzsolt F, W\u00f6lpl CP, Rist CE, Kosa R, B\u00fcchele G, Gaus W. Comparison of three instruments (QLQ-C30, SF-36, QWB-7) measuring health-related quality of life\/quality of well-being. Psychooncology. 1996;5:103\u201317.","journal-title":"Psychooncology"},{"key":"1150_CR41","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1001\/jama.1994.03520080061045","volume":"272","author":"TM Gill","year":"1994","unstructured":"Gill TM, Feinstein AR. A critical appraisal of the quality of quality-of-life measurements. JAMA. 1994;272:619\u201326.","journal-title":"JAMA"},{"key":"1150_CR42","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1007\/s00132-003-0548-5","volume":"32","author":"A Zahlten-Hinguranage","year":"2003","unstructured":"Zahlten-Hinguranage A, Bernd L, Sabo D. Amputation or limb salvage? Assessing quality of life after tumor operations of the lower extremity. Orthopade. 2003;32:1020\u20137.","journal-title":"Orthopade"},{"key":"1150_CR43","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/SLA.0000000000000869","volume":"260","author":"MF Brennan","year":"2014","unstructured":"Brennan MF, Antonescu CR, Moraco N, Singer S. Lessons learned from the study of 10,000 patients with soft tissue sarcoma. Ann Surg. 2014;260:416\u201322.","journal-title":"Ann Surg"},{"key":"1150_CR44","volume-title":"Amputation und prothesenversorgung","author":"R Baumgartner","year":"2008","unstructured":"Baumgartner R, Botta P. Amputation und prothesenversorgung. 3rd ed. Stuttgart: Georg Thieme Verlag; 2008.","edition":"3"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-017-1150-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T20:58:10Z","timestamp":1569013090000},"score":1,"resource":{"primary":{"URL":"http:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-017-1150-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,13]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1150"],"URL":"https:\/\/doi.org\/10.1186\/s12957-017-1150-3","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,13]]},"article-number":"84"}}